EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Multi-omics pan-cancer analysis of monocyte to macrophage differentiation-associated (MMD) and its significance in hepatocellular carcinoma

Suyang Bai iD, Yuping Wang iD, Yongning Zhou iD, Liang Qiao iD

Cancer Biomarkers · 2025

DOI: 10.1177/18758592251329280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, 2025. Verfasst von Suyang Bai und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malignant tumors are serious diseases that endanger human health. Therefore, it is crucial to identify markers that facilitate tumor diagnosis and prognostic assessment.

Objective

This study analyzed the significance of Monocyte to macrophage differentiation-associated (MMD) in various tumors from multiple perspectives, to explore the possibility of using MMD as a novel tumor marker.

Methods

Using the R software, an examination of MMD levels was conducted across diverse human cancers and their influence on cancer outcomes. MMD methylation, mutations, and immune infiltration analyses of various tumors were performed. A Cox regression model was used to predict the survival rates of patients with hepatocellular carcinoma (HCC). Finally, MMD expression and function were validated in Hep-3B cells.

Results

MMD was aberrantly expressed in diverse tumors and can predict patient outcomes. Methylation and functional enrichment studies indicated possible function of MMD in tumor progression, whereas immune infiltration data suggested its involvement in tumor immune evasion. Cox regression analysis revealed that elevated MMD levels were independent predictors of HCC patient outcomes. The quantitative real-time polymerase chain reaction (qPCR) data demonstrated high MMD levels in Hep-3B cells, and its suppression impeded Hep-3B cell growth.

Conclusions

MMD was abnormally expressed in various tumors and was closely associated with tumor prognosis. Thus, it had the potential to be used as a novel tumor marker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBiomarkers, TumorMacrophagesHumansPrognosisCell DifferentiationMaleFemaleDNA MethylationGene Expression Regulation, NeoplasticCell Line, TumorMonocytesMultiomics

Stichwörter der Autor:innen

MMDcell proliferationhepatocellular carcinomapan-cancerprognostic biomarker

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
  • Gansu Province Clinical Research Center for Digestive Diseases, The First Hospital of Lanzhou University, Lanzhou, China.
  • Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
  • Storr Liver Centre, the Westmead Institute for Medical Research, The University of Sydney, Westmead, Australia.

ORCID-Profile: Suyang Bai, Yuping Wang, Yongning Zhou, Liang Qiao

Förderung

  • None

Zitieren

APA

Bai, S., Wang, Y., Zhou, Y., & Qiao, L. (2025). Multi-omics pan-cancer analysis of monocyte to macrophage differentiation-associated (MMD) and its significance in hepatocellular carcinoma. Cancer Biomarkers. https://doi.org/10.1177/18758592251329280

Vancouver

Bai S, Wang Y, Zhou Y, Qiao L. Multi-omics pan-cancer analysis of monocyte to macrophage differentiation-associated (MMD) and its significance in hepatocellular carcinoma. Cancer Biomarkers. 2025. doi:10.1177/18758592251329280

BibTeX
@article{Bai2025,
  author = {Bai, Suyang and Wang, Yuping and Zhou, Yongning and Qiao, Liang},
  title = {Multi-omics pan-cancer analysis of monocyte to macrophage differentiation-associated (MMD) and its significance in hepatocellular carcinoma},
  journal = {Cancer Biomarkers},
  year = {2025},
  doi = {10.1177/18758592251329280}
}
Kostenlos starten →